Jan Jacob Schuringa

25PUBLICATIONS
83CO-AUTHORS
Haematological tumoursAtomic and molecular physicsMedical molecular engineering of nucleic acids and proteinsNutrigenomics and personalised nutritionCardiovascular medicine and haematology not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (25)

|Mar 25, 2026
Autophagy inhibition potentiates the antileukemic effect of FLT3 inhibitors and overcomes resistance in FLT3-ITD acute myeloid leukemia.

Manuela Albuquerque de Melo, Brunno Gilberto Santos de Macedo, Diego A Pereira-Martins

|Feb 19, 2026
Glutathionylated leaky mitochondrial pores as target in AML.

Diego Pereira-Martins, Jan Jacob Schuringa

|Oct 31, 2025
Metformin induces ferroptosis associated with lipidomic remodeling in AML.

Dominique Sternadt, Diego A Pereira-Martins, Prodromos Chatzikyriakou

|Mar 17, 2025
Lactate dehydrogenase A-coupled NAD<sup>+</sup> regeneration is critical for acute myeloid leukemia cell survival.

Ayşegül Erdem, Séléna Kaye, Francesco Caligiore

|Dec 24, 2024
Menin inhibitors in the treatment of acute myeloid leukemia.

Gerwin Huls, Carolien M Woolthuis, Jan Jacob Schuringa

|Jun 21, 2024
Preclinical efficacy of the potent, selective menin-KMT2A inhibitor JNJ-75276617 (bleximenib) in KMT2A- and NPM1-altered leukemias.

Min Chul Kwon, Jan Willem Thuring, Olivier Querolle

Pageof 5

Frequent Collaborators

4 joint publications

Diego Pereira-Martins

4 joint publications

Shanna M Hogeling

3 joint publications

Isabelle A van Zeventer

2 joint publications

Bert A van der Reijden